Cancer Screening means checking for cancer before its symptoms appear. The screening for cancer is done to detect certain selected cancer early so that the treatment can be more effective and to increase the positive result of the cancer treatment. The cancer screening in Nepal is recommended based on different factors such as age, sex, family history and overall health.
What Is Cancer Screening?
Cancer screening is the process of looking for cancer or pre-cancerous changes in people who do not have symptoms. The National Cancer Institute explains that screening tests aim to find cancer before symptoms develop, when it may be easier to treat successfully.
A simple way to understand cancer screening is tabulated below:
| Term | Meaning |
| Screening | Testing apparently healthy people to look for early cancer or pre-cancer |
| Diagnosis | Confirming whether cancer is present after symptoms or abnormal screening |
| Monitoring | Follow-up testing after cancer treatment or after a known abnormality |
| Risk assessment | Estimating someone’s chance of cancer based on age, family history, habits, genes, or medical history |
Screening does not mean a person has cancer. It means the doctor is checking whether further evaluation is needed.
For example, a mammogram may detect an abnormal breast area. That does not automatically mean breast cancer. It may lead to additional imaging, clinical examination, or biopsy if needed. Similarly, a positive stool test does not confirm colon cancer, but it tells the doctor that colonoscopy may be required.
Why Is Cancer Screening in Nepal Important?
Cancer screening in Nepal is important because many cancers are still diagnosed late, often after symptoms become obvious. Late diagnosis can make treatment more complex, expensive, and emotionally difficult for patients and families.
According to IARC’s CanScreen5 Nepal fact sheet, Nepal’s overall cancer incidence is estimated at 81.6 per 100,000 persons per year, while cancer mortality is 55.3 per 100,000 persons per year. Cervical cancer is listed as the most common cancer site by incidence and mortality among females, while lung cancer is listed as the most common cancer site by incidence and mortality among males.
Nepal has also introduced national level cancer prevention and control planning. The Ministry of Health and Population launched the Nepal Cancer Control Strategy 2024-2030, covering prevention, early detection, diagnosis, treatment, and palliative care.
This matters because screening is only useful when it is connected to the next steps: proper diagnosis, timely referral, and access to cancer treatment in Nepal when required.
What Types of Cancer Can Be Screened For?
Not every cancer has a recommended screening test for the general population. Good screening tests are used when evidence shows they can detect disease early enough to make a meaningful difference.
The CDC highlights screening for breast, cervical, colorectal, and lung cancers as major evidence based screening areas.
Common cancer screening tests include:
| Cancer Type | Common Screening Method | Who May Need It |
| Cervical cancer | HPV test, Pap smear, VIA | Women in recommended age groups |
| Breast cancer | Mammography, clinical breast exam | Women based on age and risk |
| Colorectal cancer | FIT/stool test, colonoscopy | Adults from recommended age groups or earlier if high risk |
| Lung cancer | Low-dose CT scan | Heavy smokers or former smokers in specific age/risk groups |
| Oral cancer | Mouth examination | Tobacco, betel nut, alcohol users, or suspicious lesions |
| Prostate cancer | PSA blood test with doctor discussion | Selected men after shared decision-making |
The right test depends on the person. A 32 year old woman, a 50 year old man who smokes, and a 45 year old person with a family history of colon cancer may need very different screening plans.
Cancer Screening in Nepal: Which Tests Are Most Relevant?
1. Cervical Cancer Screening in Nepal
Cervical cancer screening is one of the most important public health priorities in Nepal. WHO recommends starting regular cervical cancer screening at age 30 for the general population of women, with priority for women aged 30-49. WHO also notes that women living with HIV may need earlier screening from age 25.
In Nepal, older national guidance recommended VIA screening every 5 years for women aged 30-60. A 2024 PLOS Global Public Health paper notes that Nepal’s 2010 national cervical screening guideline recommended visual inspection with acetic acid every 5 years in women aged 30–60, while also reporting that Nepal has no national or regional breast cancer screening program.
Cervical screening may include:
| Test | What It Checks |
| VIA | Visual inspection of the cervix after applying acetic acid |
| Pap smear | Abnormal cervical cell changes |
| HPV DNA test | High-risk HPV infection linked to cervical cancer risk |
Cervical cancer is often preventable because screening can detect pre-cancerous changes before they become cancer. HPV vaccination is also important, but vaccination does not replace screening in adulthood.
Nepal has made progress in HPV vaccination. WHO Nepal reported that the government aims to fully vaccinate 90% of girls aged 10-14 and ensure that at least 90% of women aged 30-49 receive cervical cancer screening by 2030.
2. Breast Cancer Screening
Breast cancer screening usually involves mammography, which is an X-ray of the breast. A mammogram can sometimes detect cancer before a lump is felt.
The USPSTF recommends biennial screening mammography for women aged 40-74 years. This recommendation applies to women at average risk and some women with common risk factors, but women with very high risk may need individualized advice.
Breast screening may involve:
| Method | Purpose |
| Breast awareness | Knowing your normal breast changes and reporting concerns |
| Clinical breast exam | Doctor examination when symptoms or concerns exist |
| Mammography | Screening test for early breast cancer detection |
| Ultrasound/MRI | Additional tests in selected cases, not routine for everyone |
In Nepal, access to mammography may vary by location. People in Kathmandu and major cities may have easier access than those in rural areas. That is why awareness, timely consultation, and referral pathways are important.
A medical oncologist in Nepal may not be the first doctor you see for breast screening, but they become important if cancer is diagnosed or if treatment planning is needed.
3. Colorectal Cancer Screening
Colorectal cancer affects the colon or rectum. Screening can detect early cancer and, in some cases, pre-cancerous polyps that can be removed before they develop into cancer.
The USPSTF recommends colorectal cancer screening for adults aged 45-75 years at average risk. Screening options include annual FIT stool testing, stool DNA-FIT every 1-3 years, CT colonography every 5 years, flexible sigmoidoscopy, or colonoscopy every 10 years.
Common colorectal screening options:
| Test | Frequency Often Used | Notes |
| FIT stool test | Yearly | Non-invasive; abnormal result needs colonoscopy |
| Stool DNA-FIT | Every 1-3 years | Detects blood and DNA markers |
| Colonoscopy | Every 10 years | Can detect and remove polyps |
| CT colonography | Every 5 years | Imaging-based option |
People with a family history of colorectal cancer, inflammatory bowel disease, or previous polyps may need screening earlier than age 45.
4. Lung Cancer Screening
Lung cancer screening is not for everyone. It is usually recommended only for people at high risk due to smoking history and age.
The USPSTF recommends annual low dose CT screening for adults aged 50–80 years who have at least a 20 pack-year smoking history and currently smoke or quit within the past 15 years. Screening should stop when a person has not smoked for 15 years or has a health condition that limits the benefit of curative treatment.
A “pack year” means smoking an average of one pack per day for one year. For example:
| Smoking Pattern | Pack-Year Estimate |
| 1 pack/day for 20 years | 20 pack years |
| 2 packs/day for 10 years | 20 pack years |
| ½ pack/day for 40 years | 20 pack years |
Lung cancer screening should be done with proper counseling because low dose CT scans can find small lung nodules that may not be cancer but still require follow up.
5. Oral Cancer Screening
Oral cancer screening is especially relevant in communities where tobacco chewing, smoking, betel nut, gutkha, alcohol use, or chronic oral irritation are common.
Oral screening usually involves a careful examination of the lips, gums, tongue, cheeks, floor of mouth, and throat area. Dentists, ENT specialists, general physicians, and cancer specialists may identify suspicious patches, ulcers, lumps, or non-healing mouth sores.
Oral cancer screening is simple, but it is not a substitute for biopsy when a suspicious lesion is found.
A person should seek medical review if they have:
| Warning Sign | Why It Matters |
| Mouth ulcer not healing | Needs evaluation if persistent |
| White or red patch | May be benign, pre-cancerous, or cancerous |
| Lump in mouth or neck | Requires clinical examination |
| Pain or difficulty swallowing | Should not be ignored |
| Voice change lasting weeks | Needs assessment |
6. Prostate Cancer Screening
Prostate cancer screening is more complex because the PSA blood test can detect cancers that may never cause harm, while also missing some cancers.
The USPSTF states that for men aged 55–69, the decision to undergo PSA-based screening should be individual and made after discussing benefits and harms with a clinician. It recommends against PSA-based screening in men aged 70 and older.
This is why prostate screening should not be done casually as a “routine package” without proper counseling. Men with a family history of prostate cancer or urinary symptoms should speak with a doctor.
Screening vs Diagnostic Testing: What Is the Difference?
Many people confuse screening with diagnosis.
| Situation | Screening or Diagnosis? | Example |
| No symptoms, routine mammogram | Screening | Woman aged 45 gets mammography |
| Blood in stool | Diagnostic testing | Colonoscopy to find cause |
| Persistent cough and weight loss | Diagnostic testing | CT scan and further tests |
| HPV test in healthy woman | Screening | Cervical cancer prevention |
| Biopsy of a suspicious lump | Diagnosis | Confirms whether cancer is present |
Screening is for people without symptoms. If symptoms are already present, the person needs diagnostic evaluation, not routine screening.
Who Should Consider Cancer Screening in Nepal?
Cancer screening in Nepal should be personalized. A doctor may consider:
| Factor | Why It Matters |
| Age | Many screening tests begin at specific ages |
| Sex | Cervical and breast screening apply to specific groups |
| Family history | Cancer in close relatives may increase risk |
| Tobacco use | Raises risk of lung, oral, throat, bladder, and other cancers |
| Alcohol use | Can increase risk of several cancers |
| HPV exposure | Important for cervical cancer risk |
| Previous abnormal tests | May require closer follow-up |
| Long-term conditions | Some diseases increase cancer risk |
| Occupational exposure | Certain chemicals or dust exposure may matter |
Screening should not be based only on fear. It should be based on evidence, risk, and a clear plan for what happens if the result is abnormal.
Benefits of Cancer Screening
Cancer screening can be helpful because it may:
- Detect cancer before symptoms appear
- Find pre-cancerous changes, especially in cervical and colorectal cancer
- Allow treatment at an earlier stage
- Reduce the need for more intensive treatment in some cases
- Help high-risk people receive timely monitoring
- Improve public awareness and health-seeking behavior
For example, cervical screening can detect pre-cancerous changes, while colonoscopy can detect and remove certain polyps before they become cancerous.
The benefit is strongest when screening is done at the right age, with the right test, at the right interval, and with proper follow-up.
Limitations and Risks of Cancer Screening
Cancer screening is useful, but it is not perfect.
Possible limitations include:
| Limitation | Meaning |
| False positive | Test suggests cancer risk, but cancer is not present |
| False negative | Test misses cancer |
| Overdiagnosis | Detecting a cancer that may never have caused harm |
| Anxiety | Abnormal results can cause fear before confirmation |
| Extra procedures | Some abnormal results require biopsy or imaging |
| Cost and access | Follow-up care may be difficult in some areas |
This is why cancer screening should be guided by a qualified doctor, not selected randomly from a package list.
A good cancer specialist in Nepal will explain both benefits and limits, especially for tests such as PSA, CT scans, tumor markers, and whole-body scans.
Are Tumor Marker Blood Tests Good for Cancer Screening?
In most healthy people, tumor marker tests are not recommended as general cancer screening tools.
Tumor markers such as CEA, CA-125, CA 19-9, AFP, or PSA may be useful in specific clinical situations. However, many tumor markers can rise due to non-cancer causes. Some cancers may also be present even when tumor markers are normal.
For example:
| Tumor Marker | Common Use | Screening Concern |
| PSA | Prostate evaluation | Needs shared decision-making |
| CA-125 | Ovarian cancer monitoring in selected cases | Not reliable as routine screening for all women |
| CEA | Monitoring some colorectal cancers | Not a general screening test |
| AFP | Liver cancer risk groups, selected cases | Not for everyone |
A tumor marker should usually be ordered only when a doctor knows how the result will change the next step.
What Happens After an Abnormal Screening Result?
An abnormal result does not always mean cancer. It means further evaluation is needed.
The typical pathway is:
- Screening test is abnormal
- Doctor reviews risk factors and symptoms
- Additional test is advised
- Imaging, repeat test, endoscopy, or biopsy may be done
- Diagnosis is confirmed or ruled out
- If cancer is confirmed, staging and treatment planning begin
This step-by-step approach prevents panic and avoids unnecessary treatment.
For patients who need cancer treatment in Nepal, a multidisciplinary team may include a medical oncologist, surgical oncologist, radiation oncologist, pathologist, radiologist, oncology nurses, dietitians, counselors, and palliative care professionals.
When Should You See a Medical Oncologist in Nepal?
A medical oncologist is a doctor who specializes in cancer diagnosis coordination, chemotherapy, immunotherapy, targeted therapy, hormonal therapy, and long-term cancer care planning.
You may need to consult a medical oncologist in Nepal if:
| Situation | Why Consultation Helps |
| Cancer is confirmed by biopsy | Treatment planning is needed |
| Screening result is suspicious | Proper next steps can be planned |
| Strong family history exists | Risk-based screening may be advised |
| Previous cancer was treated | Follow-up plan is needed |
| Multiple opinions are confusing | A specialist can clarify options |
| Advanced cancer is suspected | Systemic treatment planning may be required |
Dr. Sudip Shrestha’s website describes him as Executive Chairman of Nepal Cancer Hospital and Research Center, with education in MBBS, MD Internal Medicine, and postgraduate training in Medical Oncology. His site also notes his involvement in Nepal’s cancer care development, including Bhaktapur Cancer Hospital and Nepal Cancer Hospital and Research Center.
A separate page on the same website states that he has over two decades of experience and is registered under Nepal Medical Council No. 1574.
Practical Cancer Screening Checklist for Nepal
Use this checklist as a discussion guide with your doctor.
| Age/Risk Group | Screening Discussion to Have |
| Women aged 30–49 | Cervical screening with HPV test, Pap smear, or VIA |
| Women aged 40–74 | Breast screening with mammography |
| Adults aged 45–75 | Colorectal screening options |
| Heavy smokers aged 50–80 | Low-dose CT lung screening eligibility |
| Tobacco/betel nut users | Oral examination |
| Men aged 55–69 | PSA screening discussion |
| Strong family history | Earlier or customized screening plan |
This table is not a personal prescription. It is a starting point for a doctor-patient conversation.
How Often Should Cancer Screening Be Done?
Screening frequency depends on the test.
| Screening Type | Common Interval |
| HPV DNA test | Often every 5–10 years where available, based on WHO guidance |
| VIA or Pap smear | Often every 3 years where HPV testing is not available |
| Mammography | Every 2 years for many average-risk women aged 40–74 |
| FIT stool test | Every year |
| Colonoscopy | Every 10 years for average-risk adults if normal |
| Low-dose CT lung scan | Every year for eligible high-risk people |
| PSA | Individualized after discussion |
WHO suggests HPV DNA testing intervals of 5–10 years in the general population where HPV DNA testing is used as the primary test, and VIA or cytology every 3 years where HPV testing is not operational.
Common Myths About Cancer Screening
Myth 1: “I feel healthy, so I don’t need screening.”
Screening is specifically meant for people who feel healthy. Waiting for symptoms may delay diagnosis.
Myth 2: “A normal screening test means I will never get cancer.”
A normal result reduces concern for now, but it does not remove future risk. Repeat screening may still be needed at recommended intervals.
Myth 3: “All cancer blood tests are useful for screening.”
Most tumor markers are not reliable for general cancer screening. They can be misleading without medical context.
Myth 4: “Screening always detects cancer early.”
No test is perfect. Some cancers grow quickly or may be missed. Screening reduces risk; it does not eliminate it.
Myth 5: “An abnormal screening result means cancer.”
Many abnormal screening results turn out to be non-cancerous. Follow-up testing is needed before any conclusion.
Cancer Screening in Nepal: What Should Patients Ask Their Doctor?
Before doing a screening test, ask:
- Is this test recommended for my age and risk?
- What cancer is this test looking for?
- What are the benefits and limitations?
- What happens if the result is abnormal?
- How often should I repeat it if it’s normal?
- Is there a better test based on my family history?
- Where should I go for follow-up if needed?
- What symptoms should I not ignore?
These questions help you avoid unnecessary tests and focus on evidence-based screening.
Frequently Asked Questions About Cancer Screening in Nepal
What exactly is cancer screening?
Cancer screening means checking for cancer or pre-cancerous changes before symptoms appear. It is done in healthy people based on age, sex, risk factors, and medical history.
Is cancer screening in Nepal available?
Yes, several cancer screening tests are available in Nepal, especially in major hospitals and cancer centers. Availability may vary by location, test type, and specialist access.
Which cancer screening is most important for women in Nepal?
Cervical cancer screening is highly important because cervical cancer remains a major cancer burden among women in Nepal. Breast cancer screening is also important, especially from the recommended age or earlier for high-risk women.
Should men do cancer screening too?
Yes. Men may need colorectal screening, lung cancer screening if they have a heavy smoking history, oral cancer screening if they use tobacco or betel nut, and PSA discussion for prostate cancer depending on age and risk.
Is a whole body checkup the same as cancer screening?
No. A whole-body checkup may include many tests, but not all are evidence-based cancer screening tests. Cancer screening should be targeted and medically justified.
Can cancer screening prevent cancer?
Some screening tests can help prevent cancer by finding pre-cancerous changes. Cervical screening and colorectal screening are good examples. Other tests mainly aim to detect cancer early.
Do I need screening if there is no cancer in my family?
Yes, possibly. Many cancers occur in people without a family history. Age, lifestyle, infections, and environmental factors also matter.
When should I consult a cancer specialist in Nepal?
Consult a cancer specialist if cancer is confirmed, screening results are suspicious, you have a strong family history, or you need guidance about cancer treatment in Nepal.
Conclusion
Cancer screening is not about fear. It is about timely, evidence based action.
The right screening test can detect some cancers early, identify pre-cancerous changes, and guide people toward appropriate follow-up. But screening must be done thoughtfully. Not every test is useful for every person, and abnormal results should always be interpreted by qualified doctors.
For people searching for cancer screening in Nepal, the best first step is to understand your personal risk and discuss suitable screening options with a trusted healthcare professional. If cancer is suspected or confirmed, timely consultation with an experienced cancer specialist in Nepal or medical oncologist in Nepal can help guide diagnosis, staging, and treatment planning.
Author Bio
Dr. Sudip Shrestha Senior Consultant Medical Oncologist and Executive Chairman of Nepal Cancer Hospital and Research Center. His clinical work focuses on evidence-based cancer care, patient education, and improving access to cancer treatment in Nepal.
